Answers are grounded in this paper and cite their sources.
Background: Rapid ART initiation is recommended for newly diagnosed HIV, but long-term real-world evidence from China remains limited. We compared immunological, virological, and metabolic outcomes between rapid and routine ART initiation and examined whether regimen class modified these outcomes. Methods: We retrospectively analyzed ART-naïve men who have sex with men (MSM) at the Fifth Medical Center of the Chinese PLA General Hospital. Generalized estimating equations (GEE) were used to analyze differences in virologic suppression, CD4+ cell counts, CD4/CD8 ratio, BMI, liver function, renal function, and lipids across different time points and among drugs and ART regimens. FDR analysis was performed for the results. Results: INSTI use was associated with decreased eGFR and increased TBIL in both groups (p < 0.05); in the routine initiation group, it was additionally associated with decreases in ALT and AST and increases in Cr and TC (p < 0.05). No significant differences between EFV-based and INSTI-based regimens were observed for BMI, CD4+ T-cell counts, CD4/CD8 ratio, or DBIL (all p > 0.05). No significant regimen-by-timing interactions were observed (FDR-adjusted p > 0.05 for all). Additionally, college education or above and higher baseline HIV RNA levels were independent predictors of rapid ART initiation. Conclusions: Rapid ART initiation proved feasible with sustained viral control regardless of regimen class. Both EFV-based and INSTI-based regimens were safe and effective.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: